Oral Availability and Brain Penetration of the B-RAF V600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar
Year: 2012
Type: article
Source: Molecular Pharmaceutics
DOI: 10.1021/mp3003144
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2032945022
